Click here for a message from The Motley Fool Co-Founders Tom and David Gardner.

Simon Erickson

Simon Erickson

TMFInnovator

I am a believer in the power of disruptive innovation, and that individual investors can significantly outperform the market over long periods of time. I am the lead advisor of our Motley Fool Explorer service, where we look for future-focused companies well-poised to capitalize on developing long-term trends.

Recent articles

Better Buy: Universal Display vs. Merck

We've collected the most popular companies among Fool.com readers and put them head to head in a good old-fashioned challenge we're calling The Motley Fool Better-Buy Tournament.


Better Buy: Biogen vs. Stratasys

We've collected the most popular companies among Fool.com readers, and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better Buy Tournament.


Ask a Fool: What Stock Are You Most Bullish On Right Now?

Rule Breakers analyst Simon Erickson explains why he is bullish on recently-public Veeva Systems.


Ask a Fool: Where is Fuel Cell Technology Headed?

Rule Breakers analyst Simon Erickson takes a look at a recent winner in fuel cell technology.


How Will New OLED TVs Shake Things Up in 2014?

The Consumer Electronics Show in Las Vegas introduced some exciting new products for your living room. How should we play this technology trend as investors?

3 Growth Stocks for 2014

2013 was a great year for investors. Find out how 2014 can be even better.


Will MannKind Inhale Novo Nordisk's Profits?

With a revolutionary new product set to launch in 2014, could MannKind disrupt the diabetes care market?


3 Reasons Veeva Systems Should Be on Your Watchlist

After an IPO in October, cloud-based Veeva Systems looks poised to outperform.


Is Novo Nordisk Still an Attractive Investment?

Despite a bumpy 2013, largely caused by the FDA rejection of its drug Tresiba, is Novo Nordisk a stock to add to your watchlist?


2 Health Care IT Stocks to Watch Today

Why investors should keep an eye on Cerner (Nasdaq: CERN) and athenahealth (Nasdaq: ATHN).

Bitcoin Isn't Ready to Change the Game Quite Yet

The best from the Twitterverse on the world of finance.


Could Natural Gas Soon Replace Diesel on the High Seas?

Much has been made about the opportunity for investors as transport companies explore switching from diesel to liquefied natural gas on the roads. But could the opportunity in the shipping industry be even bigger?


New Partnership for SolarCity Could Mean Cheaper Solar Energy for Homeowners

SolarCity has announced it is teaming up with Viridian. Could this be a win both for consumers and for investors?


3-D Printers: Who Are Their Customers?

3-D printing is growing quickly. Decisions being made today could have huge effects on the profits of tomorrow, so how are some of the largest players positioning themselves in the industry?


Is This Contract a Massive Win for Catamaran?

Catamaran and Cigna signed a gargantuan deal in June that will include up to $5.5 billion of revenue for each of the next 10 years. What are the implications of huge contracts such as these to the PBM industry?

3 Reasons Ellie Mae Is a Buy

Ellie Mae's stock quintupled in 2012, but it's down 11% so far in 2013. Can this growth stock return to its days of glory?


3 Reasons Catamaran Is a Buy

Catamaran shareholders have enjoyed a 2,742% gain in the past five years. Even after the run-up, here are three reasons the stock is still a buy today.